General
Preferred name
BIVALIRUDIN
Synonyms
Angiomax ()
bivalrudin ()
P&D ID
PD008021
CAS
128270-60-0
Tags
available
drug
Approved by
FDA
First approval
2000
Drug indication
Thrombocytopenia
Drug Status
approved
investigational
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Bivalirudin is a peptide congener of hirudin, the naturally occurring anticoagulant found in the saliva of the medicinal leech Hirudo medicinalis. (GtoPdb)
Compound Sets
13
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
Natural product-based probes and drugs
Other bioactive compounds
ReFrame library
External IDs
51
Properties
(calculated by RDKit )
Molecular Weight
2178.99
Hydrogen Bond Acceptors
29
Hydrogen Bond Donors
28
Rotatable Bonds
66
Ring Count
6
Aromatic Ring Count
3
cLogP
-8.12
TPSA
901.57
Fraction CSP3
0.54
Chiral centers
16.0
Largest ring
6.0
QED
0.01
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Indication
angina pectoris
Target
F2
MOA
Thrombin inhibitor
Biosynthetic Origin
Peptide (Ribosomal)
Therapeutic Indication
Antithrombotic
Therapeutic Class
Cardiovascular
Antithrombotic Agents
Source data